Michael ZürcherSep 26, 20231 min readSWIZZARD CHAMPIONSNavigating Swiss regulatory waters: insights for biotech & pharma companies
Michael ZürcherSep 4, 20232 min readINSIGHTSSwitzerland’s Commitment to Healthcare as a Leader in Health Spending and Patent Application
Michael ZürcherJul 6, 20231 min readSWIZZARD CHAMPIONSSwitzerland's commitment to quality in the pharmaceutical industry
Michael ZürcherJun 7, 20231 min readSWIZZARD CHAMPIONSWhy US Biotechs have been choosing Switzerland for over 60 years: An Interview with Jacqueline Hess
Michael ZürcherMay 11, 20232 min readCOMPANY NEWSThree key takeaways from the National Council Health Commission
Michael ZürcherApr 20, 20233 min readINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty
Michael ZürcherMar 8, 20231 min readCOMPANY NEWSMeet Swizzard’s CEO Michael Zürcher at BIO-Europe Spring in Basel
Michael ZürcherFeb 15, 20233 min readINSIGHTSMarket Access in Switzerland – or how to include medical breakthroughs on the specialties list
Michael ZürcherFeb 1, 20231 min readTEAM & PARTNERSBettina Schelbert joins Swizzard as Commercial Director
